|Conditional recommendation based on very-low-quality evidence; may consider an IL-12/23i biologic if the patient has severe psoriasis, prefers less frequent drug administration, or has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|4. Treat with an OSM over an IL-17i biologic (PICO 12)|Very low|